Therapy of small cell lung cancer: Anything new?

This publication has 17 references indexed in Scilit:

• Treatment of brain metastases of lung cancer with high doses of etoposide (VP16–213). Cooperative study from the groupe français pneumo-cancérologie
  European Journal of Cancer and Clinical Oncology, 1988
• The multidrug resistant phenotype in clinical practice; evaluation of cross resistance to ifosfamide and mesna after VP16–213, doxorubicin and vincristine (VPAV) for small cell lung cancer
  European Journal of Cancer and Clinical Oncology, 1988
• Neurotoxicity of prophylactic cranial irradiation in patients with small cell carcinoma of the lung
  European Journal of Cancer and Clinical Oncology, 1987
• Vincristine and etoposide: An effective chemotherapy regimen with reduced toxicity in extensive small-cell lung cancer
  European Journal of Cancer and Clinical Oncology, 1987
• Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer.
  Journal of Clinical Oncology, 1987
• Therapy-Related Leukemia and Myelodysplasia in Small-cell Lung Cancer
  Archives of internal medicine (1960), 1986
• Etoposide (VP-16) and cisplatin in previously treated small-cell lung cancer: clinical trial and in vitro correlates.
  Journal of Clinical Oncology, 1986
• Etoposide, cisplatin and doxorubicin in patients with small cell lung cancer: Tumor response and long term survival
  European Journal of Cancer and Clinical Oncology, 1986
• Current status of research into small cell carcinoma of the lung: Summary of the second workshop of the International Association for the Study of Lung Cancer (IASLC)
  European Journal of Cancer and Clinical Oncology, 1985
• VP-16 and cisplatin as first-line therapy for small-cell lung cancer.
  Journal of Clinical Oncology, 1985